Somnus Medical Technologies Receives
Selected Abstract
Somnus Medical Technologies Receives Milestone U.S. Patent for Treatment of Upper Airway Obstructions.
SUNNYVALE, CalifBW HealthWireJan. 27, 1998-- Company's Latest Issued Patent Delivers on Corporate Strategy to Protect Intellectual Property Somnus Medical Technologies, Inc. (NASDAQ:SOMN), an innovator in developing unique, minimally invasive treatments for upper airway disorders such as habitual ... January 27, 1998; Business Wire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Somnus Medical Technologies Receives Milestone U.S. Patent for Treatment of Upper Airway Obstructions.
2.
Somnus Medical Technologies Receives CE Mark for Somnoplasty System; New, Minimally Invasive Radiofrequency Device Commercially Available in Europe.
|
